DCB and DAPT: Where Are We Going?
Presented at TCT Middle East 2026 by Prof. Bernardo Cortese, this session highlights the rapidly expanding global adoption of Drug-Coated Balloons (DCB) and the evolving paradigm of post-procedural antiplatelet management.
As practice moves toward short, tailored antiplatelet regimens following DCB PCI, landmark ongoing trials continue to evaluate single antiplatelet therapy (SAPT) against standard DAPT across diverse and complex patient populations.
Beyond shortening antiplatelet duration, the “leave nothing behind” strategy represents a fundamental shift toward truly personalized, long-term cardiovascular care.
Watch the full video
Drug – Coated Balloons